¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Westgard multi rule technique"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • boost technique
    Ãß°¡Ä¡·á±â¹ý
  • broadband transmission technique
    ±¤ÆøÁ֯ļöÀüÆÄ±â¼ú
  • coaxial technique
    µ¿Ãà±â¹ý
  • column extraction technique
    Ä®·³ÃßÃâ±â¹ý
  • cone down technique
    Á¶»ç¿µ¿ªÃà¼Ò¹ý
  • cross fire technique
    ½ÊÀÚÆ÷È­Á¶»ç¹ý
  • cross-finger technique
    ¼Õ°¡¶ô±³Â÷¹ý, ¼öÁö±³Â÷¹ý
  • cumulative sum technique
    ´©ÀûÇÕ»ê¼ú
  • cardioplegic technique
    ½ÉÀåÁ¤Áö¼ú
  • cell labeling technique
    ¼¼Æ÷Ç¥Áö±â¹ý
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • dephase-rephase technique
    Å»À§»óÀçÀ§»ó±â¹ý
  • dilution assay technique
    Èñ¼®ºÐ¼®¹ý
  • decortication technique
    °ÑÁúÁ¦°Å¼ú, ÇÇÁúÁ¦°Å¼ú
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • boost technique
    Ãß°¡Ä¡·á±â¹ý
  • broadband transmission technique
    ±¤ÆøÁ֯ļöÀüÆÄ±â¼ú
  • cardioplegic technique
    ½ÉÀåÁ¤Áö¼ú
  • cell labeling technique
    ¼¼Æ÷Ç¥Áö±â¹ý
  • coaxial technique
    µ¿Ãà±â¹ý
  • column extraction technique
    Ä®·³ÃßÃâ±â¹ý
  • cone down technique
    Á¶»ç¿µ¿ªÃà¼Ò¹ý
  • cross fire technique
    ½ÊÀÚÆ÷È­Á¶»ç¹ý
  • cumulative sum technique
    ´©ÀûÇÕ»ê¼ú
  • decortication technique
    °ÑÁúÁ¦°Å¼ú
  • dephase-rephase technique
    Å»À§»óÀçÀ§»ó±â¹ý
  • dilution assay technique
    Èñ¼®ºÐ¼®¹ý
  • double exposure technique
    Áߺ¹¿¢½º¼±ÃÔ¿µ¼ú
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • egg concentration technique
    Áý¶õ¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Mohs technique
    ¸ð¿À¼ö¼ú¹ý
  • OBrien technique
    ¿Àºê¶óÀÌ¿£¹ý
  • Ouchterlony technique
    ¿ÀÅ©Åͷδϱâ¹ý
  • Sewells immunodiffusion technique
    ½ÃÀ£ ¸é¿ªÈ®»ê¹ý
  • adjunctive imaging technique
    º¸Á¶ ¿µ»ó ±â¹ý
  • afterloading technique
    ÈÄÀåÁø¹ý
  • analysis of variance technique
    ºÐ»ê±â¼úºÐ¼®
  • analytical technique
    ºÐ¼®±â¼ú
  • arterial puncture technique
    µ¿¸ÆÃµÀÚ¼ö±â<--±â¼ú>
  • aseptic technique
    ¹«±Õ¼ú.
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • full bladder technique
    ¹æ±¤ Ãæ¸¸¹ý
  • imagery technique
    »ó»ó ±â¹ý
  • immunoenzyme technique
    ¸é¿ªÈ¿¼Ò¹ý
  • immunoferritin technique
    ¸é¿ªÆä¸®Æ¾¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • multi-axial
  • multi-axial diagnosis
  • multi-dimensional
  • multi-disciplinary
  • multi-factorial
  • multi-factorial inheritance
  • multi-factorial polygenic
  • multi-infarct dementia
  • multi-infarct dementia => dementia
  • multi-leaf collimator
    ´Ù¿± Äݸ®¸ÞÅÍ
  • multi-locus
    ´ÙÁÂÀ§(Òýñ¨êÈ)
  • multi-section
    ´ÙÁß ÀýÆí
  • multi-step character
    ´Ù´Ü½Ä(ÒýÓ«ãÔ)¼º°Ý<--Ư¼º>
  • organic mental disorder, multi-infarct dementia
    ±âÁú¼º Á¤½ÅÀå¾Ö, ´Ù¹ß °æ»ö¼º Ä¡¸Å
  • single target multi-hit model
    ´ÜÀÏÇ¥Àû´Ù¹ßÀûÁß ¸ðµ¨
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • competitive protein-binding technique
    °æÇÕÀû ´Ü¹éÁú °áÇÕ¼ú(ÌæùêîÜÓ±ÛÜòõÌ¿ùêâú)
  • continuous flow technique
    "¿¬¼Ó(ææáÙ)È帧¼ú(âú), (ÔÒ) rapid flow technique"
  • direct fluorescent antibody technique
    Á÷Á¢ Çü±¤ Ç×ü¼ú(òÁïÈû«ÎÃù÷ô÷âú)
  • DNA-agar technique
    DNAÇÑõ(ùÎô¸) ¼ú(âú)
  • double-blind technique
    ÀÌÁ߸Ͱ˼ú(ì£ñìØîËþâú)
  • double-well technique
    ÀÌÁ¤¼ú(ì£ïÌâú)
  • everted sac technique
    ¿Ü¹ø³¶¼ú(èâÛèÒ¥âú)
  • FICA technique
    FICA ¼ú(âú)
  • fluorescent antibody technique
    Çü±¤ Ç×ü¼ú(û«ÎÃù÷ô÷âú)
  • freeze-clamp technique
    ¾ó¸² Ŭ·¥ÇÁ ¼ú(âú)
  • freeze-stop technique
    ¾ó¸²Á¤Áö(ïÎò­) ¼ú(âú)
  • gradient plate technique
    ±¸¹è ÆÇ(ÎþÛÕ÷ù)¼ú(âú)
  • indirect fluoresccnt antibody technique
    °£Á¢ Çü±¤Ç×ü¼ú(ÊàïÈû«ÎÃù÷ô÷âú)
  • Jerne plaque technique
    Á¦¸£´Ï Ç÷¹ÀÌÅ© ¼ú(âú)
  • Kleinschmidt technique
    Ŭ¶óÀν´¹ÌÆ®¼ú(âú)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gradient echo technique
    °æ»ç¿¡ÄÚ¹ý
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • inversion recovery technique
    ¿ªÀüȸº¹±â¹ý
  • localization technique
    À§Ä¡°áÁ¤¼ú
  • loop snare technique
    ¿Ã°¡¹Ì±â¹ý
  • magnetization transfer technique
    ÀÚÈ­Àü´Þ±â¼ú
  • motion artifact suppression technique
    ¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
  • navigator echo technique
    Ç×ÇØ¿¡ÄÚ±â¹ý
  • phase sensitive technique description
    À§»ó¹Î°¨¹ý¼³¸í
  • presaturation technique
    ÀüÆ÷È­¹ý
  • pulse echo technique
    ÆÞ½º¿¡ÄÚ±â¹ý
  • reduced bandwidth technique
    ´ëÆø°¨¼Ò±â¹ý
  • routine technique
    »ó¿ë¼ö±â
  • scanning technique
    ½ºÄµ±â¹ý
  • simulated echo technique
    ¸ðÀÇ¿¡ÄÚ±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SPT secretin-pancreazymin [test]; single patch technique; sleep period time; spectrin; station pull-thro...
MDR Multi-Drug Resistance
MID Multi-Infarct Dementia
MAU multi-attribute utility [model]
MAUT multi-attribute utility theory
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DEFT Direct Epifluorescent Filter Technique
EMIT Enzyme Multiplied Immuno-assay Technique
FAT Fluorescent antibody technique
FOT Forced oscillation technique
HIT Holtzman Inkblot Technique
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cryoneuroablative technique
    µ¿°á ½Å°æ ÀýÁ¦¼ú
  • cumulative sum technique
    ´©Àû ÇÕ»ê ¼ú½Ä
  • cytochemical technique
    ¼¼Æ÷ È­ÇÐÀû ±â¼ú
  • distraction technique for the cervicospinal area
    °æÃߺΠ½ÅÀü¼ú
  • diurnal electronic measuring technique
    ÁÖ°£ ÀüÀÚ ÃøÁ¤¹ý
  • double exposure technique
    Áߺ¹ X¼± ÃÔ¿µ¼ú
  • double layer fluorescent antibody technique
    ÀÌÃþ Çü±¤ Ç×ü¹ý
  • electron probe microanalysis technique
    ÀüÀÚ Å½Ä§ ¹Ì¼¼ ºÐ¼®¹ý
  • expansion investing technique
    ÆØÃ¢ ¸Å¸ô¹ý
    ¸Å¸ô ½Ã, ³³ÇüÀÇ ¿­ÆØÃ¢ ¶Ç´Â ¸Å¸ôÀçÀÇ ¿­ÆØÃ¢, °æÈ­ ÆØÃ¢À» ÀÌ¿ëÇÏ¿© ³³ÇüÀÇ ¹æ³Ã ¼öÃà ¹× ±Ý¼ÓÀÇ ÁÖÁ¶ ¼öÃ൵ µÉ ¼ö Àִ´ë·Î º¸»óÇÏ¿© ¿Íµ¿¿¡ Á¤¹ÐÇÏ°Ô ÀûÇÕÇÏ´Â Àη¹ÀÌ µî º¸Ã¶¹°À» Á¦ÀÛÇÏ·Á°í ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • extraction technique
    ÃßÃâ¹ý
  • extraoral radiographic technique
    ±¸¿Ü ÃÔ¿µ¼ú
  • fingerprinting technique
    Áö¹®¼ú
  • flow compensation gradient technique
    À¯µ¿ º¸»ó °æ»ç ±â¹ý
  • free-hand technique
    ¼Õ±â¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Gloger's rule The rule or observation that the skin of a warm-blooded animal species tends to become darker in colour towards warmer climates at lower altitudes or lower latitudes, and to become lighter in colour towards colder climates at higher altitudes or higher latitudes.
(09 Oct 1997)
Goriaew's rule Rarely used term for a rule of a blood counting field by which it is marked off in a series of squares, some of which are again subdivided into sixteen smaller ones.
(05 Mar 2000)
Chargaff's rule In DNA the number of adenine units equals the number of thymine units; likewise, the number of guanine units equals the number of cytosine units.
(05 Mar 2000)
gt-ag rule This is the observation that all introns in DNA begin with the nucleotides of GT(guanine, thymine) and end with the nucleotides AG (adenine, guanine). When the DNA is transcribed into RNA, the introns are removed from the RNA by a mechanism which recognises these beginning and ending nucleotides - in the RNA they would be CU (cytosine, uracil) and AC (adenine, cytosine).
(09 Oct 1997)
Rolleston's rule The ideal adult systolic blood pressure is 100 plus half the age, whereas the maximal physiologic pressure is 100 plus the age; of historical interest.
(05 Mar 2000)
Meyer-Overton rule <anaesthetics> Because inhalation agents act via the lipid-rich CNS cells, anaesthetic potency increases with lipid solubility.
(05 Mar 2000)
phase rule An expression of the relationships existing between systems in equilibrium: P + V = C + 2, where P is the number of phases, V the variance or degrees of freedom, and C the number of components; it also follows that the variance is, V = C + 2 -P. For H2O at its triple point, V = 1 + 2 -3 = 0, i.e., both temperature and pressure are fixed.
Synonym: Gibb's phase rule.
(05 Mar 2000)
rule A statement of conditions, effects, or phenomena typically observed in agiven situation or process.
(09 Oct 1997)
rule of bigeminy Rule that a ventricular premature beat will follow the beat terminating a long cycle. Sudden prolongation of the ventricular cycle, by changing the refractoriness in the conduction system, causes a peripheral region of bidirectional block to become transiently unidirectional and thus opens potential pathways for reentry to occur.
(05 Mar 2000)
rule of nines Method used in calculating body surface area involved in burns whereby values of 9 or 18 percent of surface area are assigned to specific regions as follows: Head and neck, 9%; anterior thorax, 18%; posterior thorax, 18%; arms, 9% each; legs, 18% each; perineum 1%.
(05 Mar 2000)
rule of outlet An obstetric rule for determining whether the pelvic outlet will permit the passage of a foetus; the sum of the posterior sagittal diameter and the transverse diameter of the outlet must equal at least 15 cm if a normal-sized baby is to pass.
(05 Mar 2000)
Clark's weight rule An obsolete rule for an approximate child's dose, obtained by dividing the child's weight in pounds by 150 and multiplying the result by the adult dose.
(05 Mar 2000)
M'Naghten rule The classic English test of criminal responsibility (1843): "to establish a defense on the ground of insanity, it must be clearly proved that, at the time of committing the act, the party accused was laboring under such a defect of reasoning, from disease of the mind, as not to know the nature and quality of the act he was doing, or if he did know it, that he did not know he was doing what was wrong."
(05 Mar 2000)
weigert-meyer rule <radiology> Applies to duplex collecting systems, upper-pole ureter, obstruction most likely to be hydronephrosis, inserts more inferiorly and medially in bladder, may insert into urethra, vagina, etc., males not incontinent: insertion above ext. Sphincter, associated with ureterocele, lower-pole ureter, reflux most likely to be pyelonephritis see also: drooping lily sign
(12 Dec 1998)
Cowling's rule An obsolete rule for a child's dose: that fraction of the adult dose obtained by dividing the age of the child at the nearest birthday by 24.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gag rule
    (¾î¶² ¹®Á¦¿¡ ´ëÇÑ)Åä·Ð ±ÝÁö·É;ÇÔ±¸·É
  • general rule
    ÃÑÄ¢
  • golden rule
    Ȳ±Ý·ü(¸¶Åº¹À½ÀÇ »ê»ó¼öÈÆ ÁßÀÇ ¸»,"¹«¾ùÀ̵çÁö ³²¿¡°Ô ´ëÁ¢À» ¹Þ°íÀÚ ÇÏ´Â ´ë·Î ³ÊÈñµµ ³²À» ´ëÁ¢Ç϶ó")
  • ground rule
    ¾ß±¸Àå¿¡ µû¸¥ ±ÔÄ¢;(»çȸ µîÀÇ)±âº»ÀûÀÎ ±ÔÄ¢
  • home rule
    ³»Á¤(Áö¹æ)ÀÚÄ¡;(¿µ)¾ÆÀÏ·£µåÀÇ ÀÚÄ¡(¹®Á¦)
  • home rule
    Áö¹æ ÀÚÄ¡
  • iron rule
    ³ÃȤÇÑ Á¤Ä¡
  • majority rule
    ´Ù¼ö°á ¿ø¸®
  • martial rule
    ±ºÁ¤
  • right-hand rule
    (Ç÷¹¹ÖÀÇ)¿À¸¥¼Õ ¹ýÄ¢
  • rule
    ±ÔÄ¢;±ÔÁ¤;·ê(law);±³ÈÆ;Á¾±Ô;¸í·É(¹ýÁ¤ÀÇ);»ó½À;½À°ü;°ü·Ê;Åë·Ê;ÁÖÀÇ;Á¤Ä¢;Áö¹è;ÅëÄ¡(control);(¼ö½Ä¾î¿Í ÇÔ²²)ÅëÄ¡±â°£;Ä¡¼¼;(°úÇÐ.¿¹¼ú»óÀÇ)¹ýÄ¢;¹æ½Ä;(¼öÇлóÀÇ)±ÔÄ¢;ÇØ¹ý;Ç¥ÁØ;ÀÚ;±¥;±¥¼±;(±¹¿Í.Á¤ºÎµîÀÌ)Áö¹èÇÏ´Ù;ÅëÄ¡ÇÏ´Ù;ÁöÈÖ(Áöµµ)ÇÏ´Ù;Á¦¾îÇÏ´Ù;(°¨Á¤À»)¾ïÁ¦ÇÏ´Ù;(
  • rule absolute
    Àý´ë¸í·É
  • rule joint
    Á¢ÀÚ
  • rule of nines
    9ÀÇ ¹ýÄ¢(È­»óÀÇ ¸éÀû°ú ¸ö Ç¥¸éÀÇ ºñÀ² °è»êÀÇ ±âÃÊ)
  • rule-of-reason
    ÇÕ¸®ÀûÀÎ;µµ¸®¿¡ ¸Â´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á